Literature DB >> 10912001

FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation and reveals functional differences between P-TEFb and TFIIH.

T Wada1, G Orphanides, J Hasegawa, D K Kim, D Shima, Y Yamaguchi, A Fukuda, K Hisatake, S Oh, D Reinberg, H Handa.   

Abstract

We report that the chromatin-specific transcription elongation factor FACT functions in conjunction with the RNA polymerase II CTD kinase P-TEFb to alleviate transcription inhibition by DSIF (DRB sensitivity-inducing factor) and NELF (negative elongation factor). We find that the kinase activity of TFIIH is dispensable for this activity, demonstrating that TFIIH-mediated CTD phosphorylation is not involved in the regulation of FACT and DSIF/NELF activities. Thus, we propose a novel transcriptional regulatory network in which DSIF/NELF inhibition of transcription is prevented by P-TEFb in cooperation with FACT. This study uncovers a novel role for FACT in the regulation of transcription on naked DNA that is independent of its activities on chromatin templates. In addition, this study reveals functional differences between P-TEFb and TFIIH in the regulation of transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912001     DOI: 10.1016/s1097-2765(00)80272-5

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  50 in total

Review 1.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

2.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells.

Authors:  H L Jenkins; C A Spencer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

Authors:  A C Goldstrohm; T R Albrecht; C Suñé; M T Bedford; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 5.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

6.  Transitions in RNA polymerase II elongation complexes at the 3' ends of genes.

Authors:  Minkyu Kim; Seong-Hoon Ahn; Nevan J Krogan; Jack F Greenblatt; Stephen Buratowski
Journal:  EMBO J       Date:  2004-01-22       Impact factor: 11.598

7.  Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.

Authors:  Koh Fujinaga; Dan Irwin; Yehong Huang; Ran Taube; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

8.  Molecular evidence for a positive role of Spt4 in transcription elongation.

Authors:  Ana G Rondón; María García-Rubio; Sergio González-Barrera; Andrés Aguilera
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

9.  Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-kappaB.

Authors:  Elena Ainbinder; Liat Amir-Zilberstein; Yuki Yamaguchi; Hiroshi Handa; Rivka Dikstein
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

10.  Covalent DNA-Protein Cross-Linking by Phosphoramide Mustard and Nornitrogen Mustard in Human Cells.

Authors:  Arnold Groehler; Peter W Villalta; Colin Campbell; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2016-01-20       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.